ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0HB0 Agios Pharmaceuticals Inc

85.29
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 69.89M43.01M94.39M117.91M203.2M41.41M14.24M26.82M
Operating Income -200.99M-320.79M-362.48M-426.33M-316.15M-387.83M-389.05M-391.49M
Pre Tax Income -198.47M-314.67M-346.03M-411.47M-327.37M1.62B-231.8M-352.09M
Net Income -198.47M-314.67M-346.03M-411.47M-327.37M1.6B-231.8M-352.09M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -4.701-6.445-5.944-6.016-4.72429.534-4.212-6.3
EBIT -200.99M-320.79M-362.48M-426.33M-316.15M1.62B-372.45M-385.43M
EBITDA -195.28M-314.36M-355.31M-418.25M-306.17M-378.59M-380.48M-384.86M

Your Recent History

Delayed Upgrade Clock